Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48201, USA; Department of Oncology, Wayne State University, Detroit, MI 48201, USA.
Department of Pharmaceutics and Biopharmacy, Philipps-Universität Marburg, Ketzerbach 63, 35037 Marburg, Germany.
J Control Release. 2014 Sep 28;190:415-23. doi: 10.1016/j.jconrel.2014.06.009. Epub 2014 Jun 13.
Polymeric siRNA delivery has been an important field for the Journal of Controlled Release since the early 2000s. With currently about 1600 publications on this topic that can be found in Scopus, we have to ask ourselves why the clinical translation has been so slow. In this review we address the importance of in vivo studies, the problem of biocompatibility of the carrier systems, intracellular entrapment and endosomal release, as well as stability issues in the presence of serum. Most of all, we ask the question: Quo vadis? Where do polymeric carriers go inside the cell and inside the body and how does this affect repeated administration? We show that the gap of knowledge on polymer biodistribution and excretion has not been closed yet and needs to be addressed to develop safe RNAi therapeutics.
聚合物 siRNA 递呈一直是《控释杂志》自 21 世纪初以来的一个重要领域。目前在 Scopus 上可以找到大约 1600 篇关于这个主题的出版物,我们不禁要问,为什么临床转化如此缓慢。在这篇综述中,我们探讨了体内研究的重要性、载体系统的生物相容性问题、细胞内捕获和内涵体释放,以及在存在血清时的稳定性问题。最重要的是,我们提出了一个问题:聚合物载体在细胞内和体内走向何方,以及这如何影响重复给药?我们表明,关于聚合物生物分布和排泄的知识差距尚未弥合,需要解决这个问题以开发安全的 RNAi 疗法。